Santen Pharmaceutical Co's total assets for Q3 2022 were $420.14B, a decrease of -1.51% from the previous quarter. SNPHF total liabilities were $― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.